Status:
COMPLETED
Anal Cancer Screening Study
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Anal Cancer
Eligibility:
MALE
18-110 years
Brief Summary
Background: * HIV-positive men who have sex with men (MSM) have rates of anal cancer that approach those of cervical cancer in women. However, unlike cervical cancer, there is no current recommended ...
Detailed Description
BACKGROUND: Human immunodeficiency virus (HIV) positive men who have sex with men (MSM) are at risk of anal cancer that approaches the risk of cervical cancer for unscreened women living in developin...
Eligibility Criteria
Inclusion
- 1 ELIGIBILITY CRITERIA:
- Any male member of KPNC who is 1) identified as HIV positive through the Kaiser HIV registry, 2) 18 years or older, can provide written, informed consent, and 3) is not currently diagnosed with anal cancer (prior to enrollment).
- 2 INCLUSION CRITERIA:
- HIV-positive men will be invited to participate, regardless of race and ethnicity, as described below if they meet the eligibility criteria. Other than having been diagnosed with anal cancer prior to enrollment, there will no other disease-based exclusions. Because of the high fraction of HIV-positive men are in fact MSM, we will not prescreen men for their sexual orientation.
- 3 EXCLUSION CRITERIA:
- The exclusion criteria will be age less than 18, a current diagnosis of anal cancer rendered prior to enrollment, an unwillingness or inability (evident mental incapacity to understand the informed consent documents) to give informed consent.
Exclusion
Key Trial Info
Start Date :
June 2 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 4 2020
Estimated Enrollment :
363 Patients enrolled
Trial Details
Trial ID
NCT00914537
Start Date
June 2 2009
End Date
November 4 2020
Last Update
November 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente
San Francisco, California, United States, 94115